Study Documents

You may need to submit certain study documents to your study record. Like most information in the study record, these documents will be posted for public access. Refer to the PRS Guided Tutorial for Uploading Study Documents for guidance. 

General Requirements 

  • Documents must be in English and PDF Archive (PDF/A) format.  
  • Every document must include a cover page with the following information:  
    • Official Title: The Official Title entered in the ClinicalTrials.gov study record. 
    • ClinicalTrials.gov ID (NCT number): If the study record is already public, the NCT number assigned to the record. 
    • Document Date: The date on which the document was most recently updated and, if needed, approved by a human subjects protection review board. This date must match that entered in the Document Date field when uploading the document.

Protocol and Statistical Analysis Plan

Results submissions to ClinicalTrials.gov for studies that have a Primary Completion Date on or after January 18, 2017 must include a copy of the most recent version of protocol and the statistical analysis plan (if not included in the protocol). An updated version, if applicable, is required with each partial results submission.  

  • The Responsible Party may redact names, addresses, and other personally identifiable information, as well as any trade secret and/or confidential commercial information (as those terms are defined in the Freedom of Information Act (5 U.S.C. 552) and the Trade Secrets Act (18 U.S.C. 1905)) contained in the document(s) prior to submission, unless such information is otherwise required to be submitted as part of clinical trial registration or results information. 

Document Definitions from ClinicalTrials.gov 

  • Study Protocol: The written description of the clinical study, including objective(s), design, and methods. It may also include relevant scientific background and statistical considerations. 
  • Statistical Analysis Plan (SAP): The written description of the statistical considerations for analyzing the data collected in the study. Includes how data are analyzed, what specific statistical methods are used for each analysis, and how adjustments are made for testing multiple variables. If some analysis methods require critical assumptions, the written description should allow data users to understand how those assumptions were verified.

Guideline for Protocol and Statistical Analysis Plan

If a clinical study protocol document has been submitted in your IRB application and approved, then use that document. (Please note that the IRB application "printer version" itself is not a protocol document.) Otherwise, you may utilize information in your approved IRB application and/or grant to create a document based on the Protocol Template. The identifying information on the cover page is required under 42 CFR 11.48(a)(5). You may choose to modify the suggested section headings, so long as you address all of the elements included in the definitions provided above.  
 

Uploading Study Documents

Get step-by-step help uploading documents in the ClinicalTrials.gov Protocol Registration and Results System (PRS). View the PRS Document Upload Tutorial.

General Requirements

Submit documents in English and save them in PDF Archive (PDF/A) format. Include a cover page with:

  • Official Title — Use the exact title entered in the ClinicalTrials.gov study record.
  • ClinicalTrials.gov ID (NCT number) — Include the number if one has been assigned.
  • Document Date — Use the date of the latest update and, when applicable, approval by the human subjects protection review board. The date on the cover page must match the Document Date field in PRS. 

Protocol and Statistical Analysis Plan

For applicable clinical trials with a Primary Completion Date on or after January 18, 2017, submit the current protocol and statistical analysis plan (SAP) with your results. Upload the SAP separately if it is a separate document. Include applicable amendments that apply across all study sites and have received review board approval when required. If either document has changed since the previous partial results submission, include the revised version with the next submission. 

  • Study protocol — Describes the study’s objectives, design, and methods. It may also include scientific background and statistical considerations.
  • Statistical analysis plan (SAP) — Explains how the study data will be analyzed, including the methods used, any adjustments for multiple comparisons, and how the study team checked key assumptions. 

Preparing Your Documents

Use the protocol document approved with your Institutional Review Board (IRB) application, if available. If you need to prepare a protocol, use the Protocol Template and draw from your approved IRB application or grant materials. Use the application’s printer version as source material for the protocol. You can adapt the template headings as long as you cover the elements described above and include the required cover-page information. 

Before submitting, the responsible party may redact personally identifiable information, trade secrets, or confidential commercial information from the protocol or SAP, except where ClinicalTrials.gov (http://clinicaltrials.gov/) registration or results reporting rules require that information. 

Informed Consent Form

The Revised Common Rule requires public posting of an informed consent form for federally conducted or supported clinical trials that are subject to the rule and have enrolled participants. 

At Pitt, studies initially approved before January 21, 2019, generally follow the Pre-2018 Rule. For a multisite trial, the posting requirement can apply if a participating institution formally transitions the trial to the revised rule while the posting window is still open. 

Who posts the form?

For awardee-led trials, the awardee is responsible for ensuring the form is posted. At Pitt, the principal investigator handles posting.

Which form should I post?

Post one IRB-approved consent form per trial. Use a version that was used to enroll participants and include the approval stamp where applicable.

When should I post it?

Post after recruitment closes and no later than 60 days after any participant’s last protocol-required study visit.

Where should I post it?

If the trial is registered on ClinicalTrials.gov and you have an approved English-language form, Pitt recommends uploading it to the study record. Otherwise, follow the HHS instructions for posting to Regulations.gov.

What if the form contains information that may need to be redacted?

Direct questions about consent form redactions to the federal department or agency funding the trial.
OHRP Informed Consent Posting Instructions